1. Home
  2. LSBK vs ACOG Comparison

LSBK vs ACOG Comparison

Compare LSBK & ACOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lake Shore Bancorp Inc.

LSBK

Lake Shore Bancorp Inc.

HOLD

Current Price

$15.04

Market Cap

110.0M

Sector

Finance

ML Signal

HOLD

Logo Alpha Cognition Inc.

ACOG

Alpha Cognition Inc.

HOLD

Current Price

$5.30

Market Cap

115.5M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
LSBK
ACOG
Founded
1891
2000
Country
United States
Canada
Employees
N/A
57
Industry
Savings Institutions
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
110.0M
115.5M
IPO Year
2006
N/A

Fundamental Metrics

Financial Performance
Metric
LSBK
ACOG
Price
$15.04
$5.30
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$18.00
AVG Volume (30 Days)
17.4K
84.0K
Earning Date
01-23-2026
11-13-2025
Dividend Yield
2.39%
N/A
EPS Growth
105.28
N/A
EPS
1.21
N/A
Revenue
$27,774,000.00
$7,427,199.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$143.70
P/E Ratio
$12.47
N/A
Revenue Growth
9.61
N/A
52 Week Low
$11.50
$3.75
52 Week High
$16.95
$11.54

Technical Indicators

Market Signals
Indicator
LSBK
ACOG
Relative Strength Index (RSI) 67.56 35.86
Support Level $14.75 $5.66
Resistance Level $15.10 $6.74
Average True Range (ATR) 0.24 0.41
MACD 0.00 -0.01
Stochastic Oscillator 89.73 0.00

Price Performance

Historical Comparison
LSBK
ACOG

About LSBK Lake Shore Bancorp Inc.

Lake Shore Bancorp Inc operates as a savings and loan holdings company. The bank's business consists of attracting retail deposits from the general public in the areas surrounding its branch offices and investing those deposits, together with funds generated from operations, in commercial real estate loans, one-to-four family residential mortgage loans, home equity lines of credit and to a lesser extent, commercial business loans, consumer loans, and investment securities. Its revenues are principally derived from interest earned on loans and investment securities.

About ACOG Alpha Cognition Inc.

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

Share on Social Networks: